#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic sclerosis pulmonary Biliary neoplasm Asthma Metastases to central nervous system Nephrotic syndrome HER2 gene amplification Thrombocytopenia Conjunctivitis allergic Endometrial adenocarcinoma Hodgkin's disease recurrent Polyneuropathy Metastatic gastric cancer Netherton's syndrome Anti-myelin-associated glycoprotein antibodies positive Chronic granulomatous disease More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung – Basic Information Von Willebrand’s disease – Basic Information Wolfram syndrome Ornithine transcarbamoylase deficiency – Diagnostics Acute respiratory distress syndrome – Diagnostics Haemophilia A without inhibitors – Life with Disease Loeys-Dietz syndrome Hereditary motor and sensory neuropathy – Diagnostics Cytokine release syndrome – Basic Information Richter’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dfv890 Dexmedetomidine Hydrochloride Lactose Cls12311 Amiloride Hydrochloride Gad20-209-Fsp-A4 Sodium Iodide (123 I) Mifepristone Sonelokimab Iopromide Holcus Lanatus Pollen Extract Abacavir Acp-017 Aon-D21 Carisbamate Dexchlorpheniramine Maleate RO7268489 Metformin Embonate Juniper Berry Oil Ribociclib More therapies…

    Learn about Your Condition

    Neurofibromatosis Diabetes insipidus Endometrial cancer stage IV Hypoxia Arteriospasm coronary Nodular melanoma Pulmonary tuberculosis Notalgia paraesthetica Stevens-Johnson syndrome Adrenoleukodystrophy Interstitial lung disease Deafness neurosensory Perthes disease Andersen-Tawil syndrome Compulsive sexual behaviour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Laiko General Hospital Of Athens

Laiko General Hospital Of Athens

Messogion Avenue 154, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study of LN-144 and LN-145 (Tumor Infiltrating Lymphocytes) in patients with solid tumors, including melanoma, head and neck cancer, and non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Non-small cell lung cancer
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Lifileucel
    • Aldesleukin
    Germany Greece Spain

  • Study of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    • Cutaneous lupus erythematosus
    • Subacute cutaneous lupus erythematosus
    Investigated Drugs:
    • Enpatoran
    Bulgaria Greece Poland Romania Spain

  • Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Crovalimab
    • Eculizumab
    Belgium Czechia Estonia France Germany Greece +7

  • Study on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Asciminib
    • Asciminib Hydrochloride
    Austria France Germany Greece Italy Poland +1

  • Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Herpes simplex
    Investigated Drugs:
    • Anhydrous Cidofovir
    • Foscarnet Sodium Hexahydrate
    • Imiquimod
    Belgium France Germany Greece Italy

  • Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Anidulafungin
    • Caspofungin Acetate
    • Clotrimazole
    Belgium Bulgaria France Germany Greece Italy +1

  • Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Nilotinib
    • Asciminib Hydrochloride
    Bulgaria Czechia France Germany Greece Hungary +4

  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Risankizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Risankizumab
    Austria Belgium Bulgaria Croatia Czechia France +13

  • Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tezepelumab
    Austria Belgium Czechia Denmark Finland Germany +7
Previous Page
1 … 29 30 31 32 33 … 38
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!